肝硬化食管胃底静脉曲张患者门静脉血栓形成的危险因素分析
Analysis of Risk Factors for Portal Vein Thrombosis in Cirrhotic Patients with Esophagogastric Varices
DOI: 10.12677/acm.2026.1662197, PDF,   
作者: 杨徐钰琳, 郭 雯, 陈雅鑫, 高 润:西安医学院研究生院,陕西 西安;西安医学院第一附属医院消化内科,陕西 西安;刘凯歌*:西安医学院第一附属医院消化内科,陕西 西安
关键词: 肝硬化食管胃底静脉曲张门静脉血栓危险因素Liver Cirrhosis Esophagogastric Varices Portal Vein Thrombosis Risk Factors
摘要: 目的:探索肝硬化食管胃底静脉曲张(Esophagogastric Varices, EGV)患者门静脉血栓形成(Portal Vein Thrombosis, PVT)的相关危险因素,为EGV患者制定预防PVT的治疗方案提供理论依据及实践指导。方法:回顾性收集我院2021年1月至2023年12月因肝硬化食管胃底静脉曲张行胃镜治疗的105例患者的临床资料(一般临床资料、实验室检查、影像学检查及胃镜检查),根据其是否确诊门静脉血栓形成分为PVT组(门静脉血栓形成组)及NPVT组(无门静脉血栓形成组),其中PVT组18例,NPVT组87例,进行单因素及多因素Logistic回归分析,探索PVT形成的危险因素。结果:单因素分析中PVT组与非PVT组比较,两组PLT、TBA、D-D及是否分流差异具有统计学意义(P < 0.05),多因素分析中PLT降低、D-D升高及伴有分流是影响肝硬化食管胃底静脉曲张患者发生PVT风险的影响因素(P < 0.05)。结论:PLT降低、D-D升高及伴有分流是肝硬化食管胃底静脉曲张患者PVT形成的独立危险因素,有必要对具有高风险的EGV患者进行门静脉血栓筛查。
Abstract: Objective: To explore the risk factors associated with Portal Vein Thrombosis (PVT) in patients with cirrhotic Esophagogastric Varices (EGV), and to provide a theoretical basis and practical guidance for developing preventive strategies against PVT in this population. Methods: A retrospective analysis was conducted on clinical data from 105 patients with cirrhotic EGV who underwent endoscopic treatment at our hospital between January 2021 and December 2023. The data included general clinical information, laboratory findings, imaging studies, and endoscopic results. Patients were divided into a PVT group (Portal Vein Thrombosis group, n = 18) and a NPVT group (Non-Portal Vein Thrombosis group, n = 87) based on confirmed PVT diagnosis. Univariate and multivariate Logistic regression analyses were performed to identify risk factors for PVT. Results: Univariate analysis showed significant differences between the PVT and non-PVT groups in PLT, TBA, D-D, and presence of shunts (P < 0.05). Multivariate analysis identified decreased PLT, elevated D-D, and presence of shunts as independent risk factors for PVT in patients with cirrhotic EGV (P < 0.05). Conclusion: Decreased PLT, elevated D-D, and presence of shunts are independent risk factors for PVT formation in patients with cirrhotic EGV. Screening for PVT is warranted in high-risk EGV patients.
文章引用:杨徐钰琳, 郭雯, 陈雅鑫, 高润, 刘凯歌. 肝硬化食管胃底静脉曲张患者门静脉血栓形成的危险因素分析[J]. 临床医学进展, 2026, 16(6): 80-88. https://doi.org/10.12677/acm.2026.1662197

参考文献

[1] Campana, L., Esser, H., Huch, M. and Forbes, S. (2021) Liver Regeneration and Inflammation: From Fundamental Science to Clinical Applications. Nature Reviews Molecular Cell Biology, 22, 608-624. [Google Scholar] [CrossRef] [PubMed]
[2] Kisseleva, T. and Brenner, D. (2021) Molecular and Cellular Mechanisms of Liver Fibrosis and Its Regression. Nature Reviews Gastroenterology & Hepatology, 18, 151-166. [Google Scholar] [CrossRef] [PubMed]
[3] Pan, J., Wang, L., Gao, F., An, Y., Yin, Y., Guo, X., et al. (2022) Epidemiology of Portal Vein Thrombosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis. European Journal of Internal Medicine, 104, 21-32. [Google Scholar] [CrossRef] [PubMed]
[4] Elkrief, L., Hernandez-Gea, V., Senzolo, M., Albillos, A., Baiges, A., Berzigotti, A., et al. (2024) Portal Vein Thrombosis: Diagnosis, Management, and Endpoints for Future Clinical Studies. The Lancet Gastroenterology & Hepatology, 9, 859-883. [Google Scholar] [CrossRef] [PubMed]
[5] 祁兴顺, 杨玲. 肝硬化门静脉血栓管理专家共识(2020年, 上海) [J]. 临床肝胆病杂志, 2020, 36(12): 2667-2674.
[6] Xing, Y., Tian, Z., Jiang, Y., Guan, G., Niu, Q., Sun, X., et al. (2022) A Practical Nomogram Based on Systemic Inflammatory Markers for Predicting Portal Vein Thrombosis in Patients with Liver Cirrhosis. Annals of Medicine, 54, 302-309. [Google Scholar] [CrossRef] [PubMed]
[7] Bunchorntavakul, C. and Reddy, K.R. (2020) Review Article: Malnutrition/sarcopenia and Frailty in Patients with Cirrhosis. Alimentary Pharmacology & Therapeutics, 51, 64-77. [Google Scholar] [CrossRef] [PubMed]
[8] Violi, F., Pignatelli, P., Castellani, V., Carnevale, R. and Cammisotto, V. (2023) Gut Dysbiosis, Endotoxemia and Clotting Activation: A Dangerous Trio for Portal Vein Thrombosis in Cirrhosis. Blood Reviews, 57, Article ID: 100998. [Google Scholar] [CrossRef] [PubMed]
[9] Peck‐Radosavljevic, M. (2007) Review Article: Coagulation Disorders in Chronic Liver Disease. Alimentary Pharmacology & Therapeutics, 26, 21-28. [Google Scholar] [CrossRef] [PubMed]
[10] Peck-Radosavljevic, M. (2000) Thrombocytopenia in Liver Disease. Canadian Journal of Gastroenterology and Hepatology, 14, 60D-66D. [Google Scholar] [CrossRef] [PubMed]
[11] Lisman, T. (2023) Bleeding and Thrombosis in Patients with Cirrhosis: What’s New? HemaSphere, 7, e886. [Google Scholar] [CrossRef] [PubMed]
[12] Derraz, I. (2022) The End of Tissue-Type Plasminogen Activator’s Reign? Stroke, 53, 2683-2694. [Google Scholar] [CrossRef] [PubMed]
[13] Kang, H., Kim, S., Park, S., Han, S., Kang, M., Kwon, S., et al. (2024) Small Leucine Zipper Protein Negatively Regulates Liver Fibrosis by Suppressing the Expression of Plasminogen Activator Inhibitor-1. Experimental Cell Research, 442, Article ID: 114258. [Google Scholar] [CrossRef] [PubMed]
[14] Thaler, J., Lisman, T., Quehenberger, P., Hell, L., Schwabl, P., Scheiner, B., et al. (2022) Intraperitoneal Activation of Coagulation and Fibrinolysis in Patients with Cirrhosis and Ascites. Thrombosis and Haemostasis, 122, 353-362. [Google Scholar] [CrossRef] [PubMed]
[15] Wong, D.J., Park, D.D., Park, S.S., Haller, C.A., Chen, J., Dai, E., et al. (2021) A PSGL-1 Glycomimetic Reduces Thrombus Burden without Affecting Hemostasis. Blood, 138, 1182-1193. [Google Scholar] [CrossRef] [PubMed]
[16] Turon, F., Driever, E.G., Baiges, A., Cerda, E., García-Criado, Á., Gilabert, R., et al. (2021) Predicting Portal Thrombosis in Cirrhosis: A Prospective Study of Clinical, Ultrasonographic and Hemostatic Factors. Journal of Hepatology, 75, 1367-1376. [Google Scholar] [CrossRef] [PubMed]
[17] 武雅荣, 张永强, 郑英, 等. 肝硬化门静脉血栓形成机制研究进展[J]. 协和医学杂志, 2025, 16(2): 439-447.
[18] Hayashi, S., Yi, S., Naito, M., Terayama, H., Buhe, S., Nakamura, Y., et al. (2006) A Case of Spontaneous Splenorenal Shunt Associated with Splenic Artery Aneurysm. Surgical and Radiologic Anatomy, 28, 311-315. [Google Scholar] [CrossRef] [PubMed]
[19] Elliott, S.P., Yeh, B. and Stoller, M.L. (2004) Radiologic Appreciation of a Spontaneous Splenorenal Shunt. Urology, 63, 776-777. [Google Scholar] [CrossRef] [PubMed]
[20] 任金正. 肝硬化脾肾或胃肾分流患者临床特点及合并胃静脉曲张内镜下治疗[D]: [硕士学位论文]. 济南: 山东大学, 2021.
[21] Zocco, M.A., Di Stasio, E., De Cristofaro, R., Novi, M., Ainora, M.E., Ponziani, F., et al. (2009) Thrombotic Risk Factors in Patients with Liver Cirrhosis: Correlation with MELD Scoring System and Portal Vein Thrombosis Development. Journal of Hepatology, 51, 682-689. [Google Scholar] [CrossRef] [PubMed]